Cohort Observational Study. The study will assess differences in quality of life, well-being and mood between persons living in a nursing home following usual care and persons living in nursing homes following a centered person care model. Initially, the follow up will last 6 months, with the possibility to be extended.
Study Type
OBSERVATIONAL
Enrollment
170
The intervention group made by persons living in nursing homes using a person centered attention model relying on two dimensions: 1. \- Attention to the person based on: * Knowledge of the person in several dimensions (biological, psychological, social, etc), interests and preferences. * Respect and acknowledge of the person. * Promotion of the autonomy. * Personalized treatment, with tailored attention and integrative cures * Protection of physical well-being, preventing damages and risks and promoting healthy habits. * Promotion of independence on daily activities. * Protection of privacy and personal matters 2. \- Positive environment based on: * Physical space, including accessibility, comfort, homely environment, with stimulating spaces for physical activity, social relationships and significant activities for the persons. * Social relationships, with proximity and collaboration with families. * Friendly organization, with empathetic professionals empowering users.
Residència "Casa del Avis"
Sant Sadurní d'Anoia, Barcelona, Spain
Residència i Centre de dia Sant Hilari
Sant Hilari Sacalm, Girona, Spain
Thriving in nursing homes
Thriving in nursing homes will be assessed with the Thriving of Older People Assessment Scale (TOPAS). Investigators will assess the change between groups.
Time frame: 0, 6 months
Quality of life
Quality of life will be assessed with the Euroqol 5D-5L. Investigators will assess the change between groups.
Time frame: 0, 6 months
Well-being
Well-being will be assessed by the WHO (Five) Well Being Index (1998 version). Investigators will assess the change between groups.
Time frame: 0, 6 months
Depressive symptoms
Cognitive impairment affects the assessment of depressive symptoms. For this reason, according to their stage using the Reisberg Global Deterioration Scale, investigators will assess the presence or absence of depressive symptoms with two tools * stage 0 to 4: investigators will consider that a person has depressive symptoms with a score of 6 or more using the 15 items Yesavage Geriatric Depression Scale, * stage 5 to 7: investigators will consider that a person has depressive symptoms with a score of 11 or more using the Cornell Depression Scale. Investigators will assess the change in the prevalence of depressive symptoms between groups.
Time frame: 0, 6 months
Neuropsychiatric inventory
Neuropsychiatric symptoms will be assessed with the Brief Neuropsychiatric inventory(NPI-Q). Investigators will assess the change between groups.
Time frame: 0,6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.